A carregar...
Case Studies in the Management of Metastatic Breast Cancer with Eribulin
Outcomes for triple-negative or hormone-refractory metastatic breast cancer (MBC) are poor and treatment options are limited. Described herein are cases of two women who developed MBC following adjuvant chemotherapy and endocrine therapy for human epidermal growth factor receptor 2 (HER2)-negative d...
Na minha lista:
| Publicado no: | Clin Med Insights Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607072/ https://ncbi.nlm.nih.gov/pubmed/26508896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S27962 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|